Impact of ferric carboxymaltose for iron deficiency at discharge after heart failure hospitalization: a European multinational economic evaluation.

Autor: McEwan P; Health Economics and Outcomes Research Ltd, Cardiff, UK., Harrison C; Health Economics and Outcomes Research Ltd, Cardiff, UK., Binnie R; Health Economics and Outcomes Research Ltd, Cardiff, UK., Lewis RD; Health Economics and Outcomes Research Ltd, Cardiff, UK., Cohen-Solal A; Hospital Lariboisière, AP-HP, INSERM U948 MASCOT, Université Paris Cité, Paris, France., Lund LH; Department of Medicine, Karolinska Institutet and Heart and Vascular Theme, Karolinska University Hospital, Stockholm, Sweden., Ohlsson M; Department of Internal Medicine, Malmö University Hospital, Malmö, Sweden., von Haehling S; Department of Cardiology and Pneumology, University of Göttingen Medical Center and German Center for Cardiovascular Research (DZHK), Göttingen, Germany., Comin-Colet J; Cardiology Department, Hospital Universitari Bellvitge, University of Barcelona and IDIBELL, Barcelona, Spain., Pascual-Figal DA; Cardiology Department, Hospital Virgen de la Arrixaca, University of Murcia, Murcia, Spain; and Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain., Wächter S; CSL Vifor, Glattbrugg, Switzerland., Dorigotti F; CSL Vifor, Glattbrugg, Switzerland., de Arellano AR; HEOR, CSL Vifor, Glattbrugg, Switzerland., Ponikowski P; Institute of Heart Diseases, Wroclaw Medical University, Wrocław, Poland., Jankowska EA; Institute of Heart Diseases, University Hospital, Wrocław, Poland.

Publikováno v: European journal of heart failure [Eur J Heart Fail] 2023 Mar; Vol. 25 (3), pp. 389-398. Date of Electronic Publication: 2023 Mar 07.

Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM-AHF trial

Autor: Metra, M, Jankowska, EA, Pagnesi, M, Anker, SD, Butler, J, Dorigotti, F, Fabien, V, Filippatos, G, Kirwan, B-A, Macdougall, IC, Rosano, G, Ruschitzka, F, Tomasoni, D, van der Meer, P, Ponikowski, P, AFFIRM-AHF investigators

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bc46a32be8c5c50d564ae2e8718184c

Minimal Clinically Important Differences in 6-Minute Walk Test in Patients With HFrEF and Iron Deficiency.

Autor: Khan MS; Division of Cardiology, Duke University Medical Center, Durham, North Carolina, USA., Anker SD; Department of Cardiology and Berlin Institute of Health Center for Regenerative Therapies, German Center for Cardiovascular Research Partner Site Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany., Friede T; Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany; German Center for Cardiovascular Research, Göttingen, Germany., Jankowska EA; Institute of Heart Diseases, Wroclaw Medical University Poland and Institute of Heart Diseases, University Hospital, Wroclaw, Poland., Metra M; Cardiology, ASST Spedali Civili and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, Civil Hospitals and University of Brescia, Brescia, Italy., Piña IL; Kimmel College of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Coats AJ; Heart Research Institute, Sydney, Australia., Rosano G; Centre for Clinical and Basic Research, Department of Medical Sciences, IRCCS San Raffaele Pisana, Rome, Italy., Roubert B; Vifor Pharma, Glattbrugg, Switzerland., Goehring UM; Vifor Pharma, Glattbrugg, Switzerland., Dorigotti F; Vifor Pharma, Glattbrugg, Switzerland., Comin-Colet J; Department of Cardiology, Bellvitge University Hospital and IDIBELL, University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain., Vanveldhuisen DJ; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Filippatos GS; University of Cyprus, Nicosia, Cyprus; National and Kapodistrian University of Athens, Athens University Hospital Attikon, Athens, Greece., Ponikowski P; Institute of Heart Diseases, Wroclaw Medical University Poland and Institute of Heart Diseases, University Hospital, Wroclaw, Poland., Butler J; Baylor Scott and White Research Institute, Dallas, Texas, USA; Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA. Electronic address: Javed.Butler@bswhealth.org.

Publikováno v: Journal of cardiac failure [J Card Fail] 2023 May; Vol. 29 (5), pp. 760-770. Date of Electronic Publication: 2022 Nov 02.

Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial.

Autor: Butler J; Baylor Scott and White Research Institute, Dallas, TX, USA.; Department of Medicine, University of Mississippi, Jackson, MS, USA., Anker SD; Department of Cardiology (CVK), Berlin, Germany.; Berlin Institute of Health Center for Regenerative Therapies (BCRT), Berlin, Germany.; German Center for Cardiovascular Research (DZHK) partner site Berlin, Berlin, Germany.; Charité Universitätsmedizin, Berlin, Germany., Lund LH; Department of Medicine, Unit of Cardiology, Karolinska Institutet, Solna, Stockholm, Sweden.; Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden., Coats AJS; University of Warwick, Warwick, UK., Filippatos G; National and Kapodistrian University of Athens, School of Medicine, Athens University, Athens, Greece.; Hospital Attikon, Athens, Greece., Siddiqi TJ; Baylor Scott and White Research Institute, Dallas, TX, USA.; Department of Medicine, University of Mississippi, Jackson, MS, USA., Friede T; Department of Internal Medicine, Göttingen, Germany.; University Medical Center Göttingen, Göttingen, Germany.; DZHK (German Center for Cardiovascular Research), Göttingen partner site, Göttingen, Germany., Fabien V; Vifor Pharma, Glattbrugg, Switzerland., Kosiborod M; Department of Cardiovascular Disease, Saint Luke's Mid America Heart Institute, Kansas City, MO, USA.; University of Missouri-Kansas City, Kansas City, MO, USA., Metra M; Cardiology, ASST Spedali Civili and University, Brescia, Italy., Piña IL; Central Michigan University College of Medicine, Mount Pleasant, MI, USA., Pinto F; Santa Maria University Hospital, CAML, CCUL, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal., Rossignol P; X Université de Lorraine, INSERM, Centre d'Investigations Cliniques-Plurithématique 1433, INSERM Unit 1116, Centre Hospitalier Régional Universitaire (CHRU) de Nancy, Nancy, France.; F-CRIN INI-CRCT, Nancy, France., van der Meer P; Department of Cardiology, University Medical Center Groningen, Groningen, the Netherlands., Bahit C; INECO Neurociencias Oroño, Rosario, Santa Fe, NM, USA., Belohlavek J; Clinic of Cardiology and Angiology, General University Hospital Prague, Prague, Czech Republic., Böhm M; Klinik für Innere Medizin III, Saarland University, Homburg/Saar, Germany., Brugts JJ; Erasmus MC University Medical Center, Rotterdam, the Netherlands., Cleland JGF; Institute of Health & Wellbeing, University of Glasgow, Glasgow, UK., Ezekowitz J; Faculty of Medicine & Dentistry, University of Alberta, Alberta, Canada., Bayes-Genis A; Cardiology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, CIBERCV, Spain., Gotsman I; Hadassah Medical Centre, Jerusalem, Israel., Goudev A; Department of Emergency Medicine, Medical University of Sofia, Sofia, Bulgaria., Khintibidze I; Alexandre Aladashvili Clinic, Tbilisi State Medical University, Tbilisi, Georgia., Lindenfeld J; Department of Medicine, Vanderbilt University Medical Centre, Nashville, TN, USA., Mentz RJ; Department of Medicine, Duke University School of Medicine, Durham, NC, USA., Merkely B; Semmelweis University Heart and Vascular Center, Budapest, Hungary., Montes EC; Heart Institute of Queretaro, Santiago de Querétaro, Mexico City, Mexico., Mullens W; Ziekenhuis Oost Limburg Genk and University Hasselt, Belgium., Nicolau JC; Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina.; Universidade de Sao Paulo, Sao Paulo, SP, Brazil., Parkhomenko A; Hospital Oost-Limburg, Genk, Belgium., Ponikowski P; Insitute of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland., Seferovic PM; Faculty of Medicine Belgrade, Serbia.; Serbian Academy of Sciences and Arts, Serbia., Senni M; University of Milano - Bicocca, Cardiovascular Department, Papa Giovanni XXIII Hospital, Bergamo, Italy., Shlyakhto E; Almazov Federal Heart, Blood and Endocrinology Centre, Saint-Petersburg, Russia., Cohen-Solal A; Université de Paris, INSERM U942, APHP, Hospital Lariboisiere, Paris, France., Szecsödy P; Vifor Pharma, Glattbrugg, Switzerland., Jensen K; Vifor Pharma, Glattbrugg, Switzerland., Dorigotti F; Vifor Pharma, Glattbrugg, Switzerland., Weir MR; Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA., Pitt B; Division of Cardiology, University of Michigan, Ann Arbor, MI, USA.

Publikováno v: European heart journal [Eur Heart J] 2022 Nov 01; Vol. 43 (41), pp. 4362-4373.

EE326 Alleviating the Burden of Iron Deficiency in Heart Failure: A Multinational European Study

Autor: McEwan, P, Harrison, C, Cohen-Solal, A, Lund, LH, Ohlsson, M, von Haehling, S, Comin-Colet, J, Pascual-Figal, DA, Ponikowski, P, Wächter, S, Dorigotti, F, Ramirez de Arellano Serna, A, Jankowska, EA

Publikováno v: In Value in Health December 2022 25(12) Supplement:S118-S118